Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients

by Susan Cedra, Susanne Wiegand, Marlen Kolb, Andreas Dietz, Gunnar Wichmann
Published 2017-09-01

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets

by Gunnar Wichmann, Clara Gaede, Susanne Melzer, Jozsef Bocsi, Sylvia Henger, Christoph Engel, Kerstin Wirkner, John Ross Wenning, Theresa Wald, Josefine Freitag, Maria Willner, Marlen Kolb, Susanne Wiegand, Markus Löffler, Andreas Dietz, Attila Tárnok
Published 2019-06-01